SEC ownership of Eikon Therapeutics, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001861123.

Comparable stake leader

Column Group IV GP, LP

Disclosed value leader

Column Group IV GP, LP

Comparable rows

50/50

Latest evidence

03 Sep 2026

Top shareholders Insider holders Latest transactions
Public ticker
EIKN on Nasdaq
Parsed ownership sources
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
Largest SEC-reported holder
Column Group IV GP, LP
Ranking: Comparable ownership first, then disclosed value
Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Column Group IV GP, LP
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
03 Sep 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001861123
Issuer location
Millbrae, CA

Ownership snapshot

Top shareholders of Eikon Therapeutics, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Column Group IV GP, LP
Disclosed value leader
Column Group IV GP, LP
Comparable rows
50/50
Latest evidence
03 Sep 2026
13D/G 3/4/5 13F Lead comparable stake: 12% 13D/G row: Column Group IV GP, LP Showing 1-8 of 50 holder rows.

Quick read

Column Group IV GP, LP leads the comparable SEC ownership view at 12%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Column Group IV GP, LP's linked filing trail.
Comparable ownership Top 5
Column Group IV GP, LP 12%
FMR LLC 9.2%
Foresite Capital Fund IV, L.P. 7.7%
BlackRock Portfolio Management LLC 5.5%
Roger M. Perlmutter 5.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Column Group IV GP, LP
13D/G 3/4/5
Tim Kutzkey · 10%+ Owner
13D/G 3/4/5
12%
$131,204,153
6,353,712 shares
 $0 06 Feb 2026
FMR LLC
13F 13D/G
Company
13F 13D/G
9.2%
from 13D/G
$65,179,504
4,994,254 shares
mixed-class rows
 — 30 Jun 2026
Foresite Capital Fund IV, L.P.
13D/G
James B. Tananbaum
13D/G
7.7%
—
4,148,519 shares
 $0 04 Feb 2026
BlackRock Portfolio Management LLC
13D/G
13D/G
5.5%
$29,456,850
3,002,737 shares
 $0 31 Mar 2026
Roger M. Perlmutter
13D/G 3/4/5
PERLMUTTER ROGER M · Chief Executive Officer and Director, Director
13D/G 3/4/5
5.2%
$28,555,598
2,893,171 shares
 $0 04 Feb 2026
Abu Dhabi Investment Authority
13D/G
13D/G
5.2%
—
2,816,714 shares
 $0 04 Feb 2026
Innovation Endeavors III LP
13D/G
13D/G
5%
$26,878,241
2,723,226 shares
 $0 31 Mar 2026
Column Group IV, LP
3/4/5
10%+ Owner
3/4/5
11%
$76,461,909
5,869,343 shares
 +$1,031,045 03 Sep 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$8,248,360.

Buys
$8,248,360
Insiders: 8
Sells
$0
Insiders: 0
Net
+$8,248,360
Shares: +713,600
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 713,600 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 713,600 0 $8,248,360 $0 +$8,248,360
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 21 reporting-owner rows connected to Eikon Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
21
Largest Forms 3/4/5 holder
Column Group IV GP, LP
Net 12M change
+$8,248,360
Latest report
03 Sep 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Column Group IV GP, LP 10%+ Owner $76,461,909 +$1,031,045 +1.4% Mixed 03 Sep 2026
Column Group Opportunity III, LP 10%+ Owner $76,461,909 +$1,031,045 +1.4% Mixed 03 Sep 2026
TCG Opportunity III GP, LLC 10%+ Owner $76,461,909 +$1,031,045 +1.4% Mixed 03 Sep 2026
Tim Kutzkey 10%+ Owner $76,461,909 +$1,031,045 +1.4% Mixed 03 Sep 2026
Peter Svennilson 10%+ Owner $76,461,909 +$1,031,045 +1.4% Mixed 03 Sep 2026
Column Group Opportunity III GP, LP 10%+ Owner $76,461,909 +$1,031,045 +1.4% Mixed 03 Sep 2026
Column Group IV-A, LP 10%+ Owner $76,461,909 +$1,031,045 +1.4% Mixed 03 Sep 2026
Column Group IV, LP 10%+ Owner $76,461,909 +$1,031,045 +1.4% Mixed 03 Sep 2026
Michael A. Klobuchar Chief Operating Officer Mixed 02 Mar 2026
Josh Wolfe Director, 10%+ Owner Mixed 04 Feb 2026
Lux Venture Partners V, LLC 10%+ Owner Mixed 04 Feb 2026
Alfred Lloyd Bowie Jr. Chief Financial Officer Mixed 02 Mar 2026
Ma. Fatima Francisco Director Mixed 15 Jun 2026
Benjamin Bruno Thorner General Counsel and Chief Business Officer Mixed 02 Mar 2026
Roger M. Perlmutter Chief Executive Officer and Director, Director Mixed 02 Mar 2026
Kenneth C. Frazier Director Mixed 02 Mar 2026
David W. Meline Director Mixed 04 Feb 2026
Roy D. Baynes Chief Medical Officer Mixed 02 Mar 2026
Foresite Capital Management IV, LLC 10%+ Owner Mixed 04 Feb 2026
Leon Chen Director Mixed 04 Feb 2026

Recent insider transactions for Eikon Therapeutics, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Column Group IV GP, LP EIKN Common Stock Purchase $1,031,045 $11.56 89,200 89,200 03 Sep 2026 See footnote
Column Group IV GP, LP EIKN Common Stock Purchase $1,031,045 $11.56 89,200 89,200 03 Sep 2026 See footnote
Column Group IV GP, LP EIKN Common Stock Purchase $1,031,045 $11.56 89,200 89,200 03 Sep 2026 See footnote
Column Group IV GP, LP EIKN Common Stock Purchase $1,031,045 $11.56 89,200 89,200 03 Sep 2026 See footnote
Column Group IV GP, LP EIKN Common Stock Purchase $1,031,045 $11.56 89,200 89,200 03 Sep 2026 See footnote
Column Group IV GP, LP EIKN Common Stock Purchase $1,031,045 $11.56 89,200 89,200 03 Sep 2026 See footnote
Column Group IV GP, LP EIKN Common Stock Purchase $1,031,045 $11.56 89,200 89,200 03 Sep 2026 See footnote
Column Group IV GP, LP EIKN Common Stock Purchase $1,031,045 $11.56 89,200 89,200 03 Sep 2026 See footnote
Michael A. Klobuchar EIKN Stock Option (Right to Buy) Award 87,157 87,157 02 Mar 2026 Direct
Robert Luther Huffines EIKN Stock Option (Right to Buy) Award 25,873 25,873 02 Mar 2026 Direct
Kenneth C. Frazier EIKN Stock Option (Right to Buy) Award 25,873 25,873 02 Mar 2026 Direct
Roger M. Perlmutter EIKN Stock Option (Right to Buy) Award 268,176 268,176 02 Mar 2026 Direct
Benjamin Bruno Thorner EIKN Stock Option (Right to Buy) Award 67,044 67,044 02 Mar 2026 Direct
Roy D. Baynes EIKN Stock Option (Right to Buy) Award 134,088 134,088 02 Mar 2026 Direct
Alfred Lloyd Bowie Jr. EIKN Stock Option (Right to Buy) Award 67,044 67,044 02 Mar 2026 Direct
Roger M. Perlmutter EIKN Common Stock Conversion of derivative security 284,857 284,857 06 Feb 2026 See Footnote
Roger M. Perlmutter EIKN Series D Preferred Stock Conversion of derivative security -100% -855,512 0 06 Feb 2026 See Footnote
Roger M. Perlmutter EIKN Series A-1 Preferred Stock Conversion of derivative security -100% -1,268,891 0 06 Feb 2026 See Footnote
Column Group IV GP, LP EIKN Common Stock Purchase 91.7% 630,881 1,319,164 06 Feb 2026 By The Column Group Opportunity III, LP
Column Group IV GP, LP EIKN Common Stock Purchase 49.9% 49,556 148,840 06 Feb 2026 By The Column Group IV-A, LP
Column Group IV GP, LP EIKN Common Stock Purchase 50% 1,437,323 4,312,139 06 Feb 2026 By The Column Group IV, LP
Column Group IV GP, LP EIKN Common Stock Conversion of derivative security 688,283 688,283 06 Feb 2026 By The Column Group Opportunity III, LP
Column Group IV GP, LP EIKN Common Stock Conversion of derivative security 2861.9% 95,932 99,284 06 Feb 2026 By The Column Group IV-A, LP
Column Group IV GP, LP EIKN Common Stock Conversion of derivative security 4413.7% 2,811,125 2,874,816 06 Feb 2026 By The Column Group IV, LP
Column Group IV GP, LP EIKN Series D Preferred Stock Conversion of derivative security -100% -5,133,076 0 06 Feb 2026 By The Column Group Opportunity III, LP
Column Group IV GP, LP EIKN Series C-1 Preferred Stock Conversion of derivative security -100% -28,229 0 06 Feb 2026 By The Column Group IV-A, LP
Column Group IV GP, LP EIKN Series C-1 Preferred Stock Conversion of derivative security -100% -827,278 0 06 Feb 2026 By The Column Group IV, LP
Column Group IV GP, LP EIKN Series A-1 Preferred Stock Conversion of derivative security -100% -357,216 0 06 Feb 2026 By The Column Group IV-A, LP
Column Group IV GP, LP EIKN Series A-1 Preferred Stock Conversion of derivative security -100% -10,467,526 0 06 Feb 2026 By The Column Group IV, LP
Column Group IV GP, LP EIKN Series A Preferred Stock Conversion of derivative security -100% -330,000 0 06 Feb 2026 By The Column Group IV-A, LP
Column Group IV GP, LP EIKN Series A Preferred Stock Conversion of derivative security -100% -9,670,000 0 06 Feb 2026 By The Column Group IV, LP
Josh Wolfe EIKN Common Stock Conversion of derivative security 5,695,010 2,387,705 06 Feb 2026 See footnote
Josh Wolfe EIKN Series D Preferred Stock Conversion of derivative security -100% -10,266,152 0 06 Feb 2026 See footnote
Josh Wolfe EIKN Series C-1 Preferred Stock Conversion of derivative security -100% -1,450,614 0 06 Feb 2026 See footnote
Josh Wolfe EIKN Series C Preferred Stock Conversion of derivative security -100% -303,360 0 06 Feb 2026 See footnote
Josh Wolfe EIKN Series B-1 Preferred Stock Conversion of derivative security -100% -8,815,537 0 06 Feb 2026 See footnote
Josh Wolfe EIKN Series B Preferred Stock Conversion of derivative security -100% -1,327,300 0 06 Feb 2026 See footnote
Josh Wolfe EIKN Series A-1 Preferred Stock Conversion of derivative security -100% -10,309,278 0 06 Feb 2026 See footnote
Josh Wolfe EIKN Series A Preferred Stock Conversion of derivative security -100% -10,000,000 0 06 Feb 2026 See footnote
Lux Venture Partners V, LLC EIKN Common Stock Conversion of derivative security 5,695,010 2,387,705 06 Feb 2026 See Footnote
Lux Venture Partners V, LLC EIKN Series D Preferred Stock Conversion of derivative security -100% -10,266,152 0 06 Feb 2026 See Footnote
Lux Venture Partners V, LLC EIKN Series C-1 Preferred Stock Conversion of derivative security -100% -1,450,614 0 06 Feb 2026 See Footnote
Lux Venture Partners V, LLC EIKN Series C Preferred Stock Conversion of derivative security -100% -303,360 0 06 Feb 2026 See Footnote
Lux Venture Partners V, LLC EIKN Series B-1 Preferred Stock Conversion of derivative security -100% -8,815,537 0 06 Feb 2026 See Footnote
Lux Venture Partners V, LLC EIKN Series B Preferred Stock Conversion of derivative security -100% -1,327,300 0 06 Feb 2026 See Footnote
Lux Venture Partners V, LLC EIKN Series A-1 Preferred Stock Conversion of derivative security -100% -10,309,278 0 06 Feb 2026 See Footnote
Lux Venture Partners V, LLC EIKN Series A Preferred Stock Conversion of derivative security -100% -10,000,000 0 06 Feb 2026 See Footnote
Foresite Capital Management IV, LLC EIKN Common Stock Purchase 4.4% 55,555 1,318,983 04 Feb 2026 See Footnote
Foresite Capital Management IV, LLC EIKN Common Stock Conversion of derivative security 4,041,687 1,943,682 04 Feb 2026 See Footnote
Foresite Capital Management IV, LLC EIKN Series D Preferred Stock Conversion of derivative security -100% -5,133,076 0 04 Feb 2026 See Footnote
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .